The global interventional radiology market is set for steady growth, with demand forecasted to reach USD 42.7 billion by 2033, expanding at a compound annual growth rate (CAGR) of 5%. This growth is being driven by the increasing preference for minimally-invasive procedures, which offer cost-effectiveness, reduced hospital stays, and quicker recovery times compared to traditional surgical methods.
Technological advancements in imaging technology, particularly in modalities such as MRI, are playing a pivotal role in driving the market forward. These innovations are improving the precision and effectiveness of interventional radiology procedures, making them more accessible and attractive to both patients and healthcare providers. As developing countries continue to embrace these technologies, interventional radiology is expected to see strong economic growth, especially in regions with rising healthcare infrastructure and a growing focus on minimally-invasive treatments.
Furthermore, the soaring adoption of MRI technology is anticipated to significantly impact market growth in the coming years, enhancing diagnostic capabilities and treatment outcomes. However, while opportunities abound, complex regulatory frameworks in emerging markets may present challenges, potentially limiting market expansion in these regions.
Request a Sample Copy Now : https://www.fmisamplereport.com/sample/rep-gb-14334
Key Takeaways:
- The global interventional radiology market is projected to grow to USD 42.7 billion by 2033, at a CAGR of 5%.
- Cost-effectiveness and shorter hospital stays associated with minimally-invasive procedures are driving market demand.
- Technological advancements in imaging technologies, particularly MRI, are expected to accelerate market growth, especially in developing countries.
- Regulatory complexities in emerging markets could pose challenges to market expansion.
Global interventional radiology demand is forecast to reach USD 42.7 Billion and grow at 5% CAGR.
- The cost-effectiveness of minimally-invasive procedures and shorter hospital stays are driving a growing trend of minimally-invasive procedures
- Technological advancement in imaging technology promotes economic growth primarily in developing countries.
- Market growth is anticipated to be positively affected by the soaring adoption of MRI in the near future
- Regulations in emerging markets will be complex, putting a restraint on the market.
How Intense is the Competition in the Interventional Radiology Market?
Among the industry’s leading participants are Koninklijke Philips, GE Healthcare, Siemens Healthineers, Fujifilm Healthcare, Canon Medical Systems Corporation, and Toshiba Medical Systems. These industry leaders are deploying sophisticated technology to address a sizable portion of the consumer market’s unmet demands.
Recent Developments in the Interventional Radiology Market:
- Samsung Electronics Co. Ltd will debut premium diagnostic imaging solutions in ultrasound, digital radiography, and mobile computed tomography at the Radiological Society of North America’s (RSNA) 2020 meeting in December 2020. This strategic move aided the corporation in diversifying its product offering.
- GE Healthcare, a part of General Electric Company, announced the commercial debut of the LOGIQ E10 ultrasound system in March 2018. The system has complete capabilities for enhancing precise pictures used to treat a variety of disorders. The system has a remote control application, which aids in increasing efficiency and patient satisfaction. This product introduction enabled the business to reach a broader consumer base.
Key Segments
By Product:
- MRI Systems
- CT Scanners
- Ultrasound Imaging Systems
- Angiography Systems
- Others
By Procedure:
- Angioplasty
- Biopsy
- Embolization
- Peripheral Embolization
- Prostatic Artery Embolization
- Genicular Artery Embolization
- Fibroid
- Others
- Thrombolysis
- Vertebroplasty
- Nephrostomy
- Interventional Oncology
- MSK Intervention
- Others
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Others
By Application:
- Cardiology
- Oncology
- Urology
- Gastroenterology
- Obstetrics
- Gynecology
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube